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In addition to the classical phenotype, Staphylococcus aureus may exhibit the small
colony-variant (SCV) phenotype, which has been associated with chronic, persistent and/or
relapsing infections. SCVs are characterized by common phenotypic features such as slow
growth, altered susceptibility to antibiotic agents and pathogenic traits based on increased
internalization and intracellular persistence. They show frequently auxotrophies mainly
based on two different mechanisms: (i) deficiencies in electron transport as shown for
menadione- and/or hemin-auxotrophs and (ii) thymidylate biosynthetic-defective SCVs. To
get a comprehensive overview of the metabolic differences between both phenotypes,
we compared sets of clinically derived menadione-, hemin- and thymidine-auxotrophic
SCVs and stable site directed mutants exhibiting the SCV phenotype with their
corresponding isogenic parental strains displaying the normal phenotype. Isotopologue
profiling and transcriptional analysis of central genes involved in carbon metabolism,
revealed large differences between both phenotypes. Labeling experiments with
[U-13C6]glucose showed reduced 13C incorporation into aspartate and glutamate from all
SCVs irrespective of the underlying auxotrophism. More specifically, these SCVs showed
decreased fractions of 13C2-aspartate and glutamate; 13C3-glutamate was not detected
at all in the SCVs. In comparison to the patterns in the corresponding experiment with
the classical S. aureus phenotype, this indicated a reduced carbon flux via the citric
acid cycle in all SCV phenotypes. Indeed, the aconitase-encoding gene (acnA) was found
down-regulated in all SCV phenotypes under study. In conclusion, all SCV phenotypes
including clinical isolates and site-directed mutants displaying the SCV phenotype were
characterized by down-regulation of citric acid cycle activity. The common metabolic
features in central carbon metabolism found in all SCVs may explain similar characteristics
of the S. aureus SCVs irrespective of their auxotrophism as well as the specific genetic
and/or regulatory backgrounds.
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INTRODUCTION
Staphylococcus aureus (S. aureus) has been recognized as one of
the most important human pathogens world-wide causing a wide
range of mild to serious infections within and outside the hospital
aggravated by the dissemination of different methicillin-resistant
S. aureus (MRSA) lineages (Lowy, 1998; David and Daum, 2010).
Besides its capability to cause acute infections, S. aureus can cause
chronic courses of infection despite adequate antimicrobial ther-
apy that are often associated with a defined S. aureus phenotype,
designated as small-colony variants (SCVs) (Proctor et al., 2006).
SCVs represent a sub-population with distinct phenotypic and
pathogenic traits adapted to an intracellular lifestyle (von Eiff
et al., 2001, 2006; Sachse et al., 2010; Tuchscherr et al., 2010). As
main feature, they show frequently auxotrophies (auxotrophism)
for menadione, hemin and/or thymidine, however, strains with-
out any detectable auxotrophy or with other auxotrophies includ-
ing those for CO2 and thiamin have been described (Thomas,
1955; von Eiff et al., 1997; Kahl et al., 2003; Chatterjee et al.,
2008; Lannergård et al., 2008; Gómez-González et al., 2010).
The best-investigated and most prevalent SCV phenotypes, the
menadione and/or hemin autotrophic SCVs as well as thymidine
autotrophic SCVs, are characterized by deficiencies in the electron
transport and in the thymidylate biosynthetic pathway, respec-
tively (von Eiff et al., 1997; Chatterjee et al., 2008). It has been
shown for hemin and menadione auxotrophic SCVs, based on
mutations in hemB and menD (von Eiff et al., 1997; Kohler et al.,
2003, 2008), that genes involved in the central metabolic processes
were affected. Transcriptomic and proteomic approaches revealed
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Table 1 | Bacterial strains used in this study.
Strain designation in this study Description Source
CLINICALLY DERIVED STRAIN PAIRS
IWT Clinical wild-type (strain 1549I) This study
ISCV Clinical SCV; heme auxotroph (strain 1549III) This study
IIIWT Clinical wild-type (strain F2418II) Chatterjee et al., 2008
IIISCV Clinical SCV; thymidine auxotroph (strain F2418) Chatterjee et al., 2008
VWT Clinical wild-type (strain 22616/1) Lannergård et al., 2008
VSCV Clinical SCV; menadione auxotroph (strain 22616/3) Lannergård et al., 2008
WT3878 Clinical wild-type (strain 3878I) Kriegeskorte et al., 2011
cSCV3878 Clinical SCV (strain3878III) Kriegeskorte et al., 2011
STABLE IN VITRO GENERATED MUTANTS
IIWT Wild type (strain 8325-4) O’Neill, 2010
IISCV hemB SCV (strain 8325-4) This study
IVWT Wild type (strain SH1000) O’Neill, 2010
IVSCV thyA SCV (strain SH1000) Kriegeskorte et al., 2012
VIWT Wild type (strain 6850) Fraunholz et al., 2013
VISCV Menadione auxotroph SCV (strain JB1; generated from strain 6850) Balwit et al., 1994
hemB3878 Site directed hemB mutant SCV (generated from wild-type strain 3878I) Kriegeskorte et al., 2011
KM3878 Complementation of hemB3878 with pCX19 hemB Kriegeskorte et al., 2011
REV3878 Spontaneous revertant strain of cSCV3878 Kriegeskorte et al., 2011
G3878 Gentamicin -induced SCV of WT3878 (menadione auxotroph) Kriegeskorte et al., 2011
FIGURE 1 | 13C-Excess in alanine, aspartate and glutamate from
S. aureus strains grown with [U-13C6]glucose (A). Error bars indicate
the standard deviation of three technical replicates. WT (clinically isolated
normal phenotype), REV (spontanous revertant of the clinical SCV) and
KM (complemented hemB mutant with an intact hemB gene in trans)
display an S. aureus wild-type phenotype. cSCV (clinically isolated SCV
phenotype), hemB (site-directed hemB mutant of WT) and G
(gentamicin induced SCV phenotype) display a S. aureus SCV phenotype.
Relative contribution of 13C-isotopologs carrying one to five 13C-atoms
(M+1–M+5) in aspartate (B) and glutamate (C). The group of M+X
comprises all isotopologs of aspartate and glutamate with only X labeled
carbon units irrespective of the location within the molecule.
Isotopologue patterns of amino acids with <1% 13C-excess are not
shown due to the high standard deviations.
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considerable differences between the wild type and SCV pheno-
types especially in the fermentative pathways (Kohler et al., 2003,
2008; Seggewiss et al., 2006). However, because clinically derived
SCVs tend to revert quickly back into the wild type phenotype,
most of SCV studies were performed with genetically defined,
stable mutants. A recent proteomic study comparing a clini-
cally derived SCV with a corresponding hemB mutant SCV and
a gentamicin-induced SCV revealed common, but also distinct
features between naturally occurring and genetically generated
SCVs apart from changes triggered by the mutational inactiva-
tion of the electron transport chain (Kriegeskorte et al., 2011).
Nevertheless, the complex metabolic and physiological changes
along with the SCV phenotype are still not fully understood and
more multifaceted than revealed from studies with genetically
defined mutants displaying the SCV phenotype.
The aim of this study was to get additional insights into
the metabolic properties of S. aureus SCVs as compared to
their corresponding isogenic normal phenotype. For this pur-
pose, we investigated a comprehensive set of SCVs including
both clinically derived strains and stable site directed mutants by
13C-isotopologue profiling and transcriptional analysis.
MATERIALS AND METHODS
BACTERIAL STRAINS AND CULTURE CONDITIONS
Clinical S. aureus wild types and SCVs were recovered in paral-
lel from patients with chronic infections (e.g., osteomyelitis and
cystic fibrosis). Clonality was verified by SmaI macrorestriction
analyses by pulsed-field gel electrophoresis (PFGE). Strains used
in this study were summarized in Table 1. The S. aureus isolates
were grown on Columbia sheep blood agar and tryptic soy agar at
37◦C for 24–48 h. Liquid cultures were grown aerobically in 50ml
tryptic soy broth (TSB) in 500ml flasks at 37◦C and 160 rpm.
For labeling experiments (isotopolog profiling) TSB without dex-
trose (Bacto Tryptic Soy without dextrose, BD, New Jersey, USA)
including 17 g of pancreatic digest of casein, 3 g of enzymatic
digest of sojabean meal, 5 g of sodium chloride and 2.5 g of
dipotassium phosphate was used. Themediumwas supplemented
with 2.5 g of [U-13C6]glucose.
CELL ISOLATION AND GROWTH CURVE ANALYSIS
For isotopolog profiling, 50ml cultures were inoculated to an
optical density of 0.05 (578 nm) from overnight cultures. Cells
were harvested after 540min by centrifugation (10min, 5000× g,
FIGURE 2 | Growth curve analysis of S. aureus isolates with
normal and SCV phenotype. Heme-auxotrophic (A),
thymidine-auxotrophic (B) and menadione-auxotrophic (C). Strain pairs I,
III, and V represent clinical isolates consisting of a normal phenotype
(WT) and a SCV phenotype (SCV). Strain pairs II, IV, and VI consist
of a normal phenotype and an in vitro generated SCV phenotype. The
optical density of the cultures was measured at 595 nm and values
were plotted against the time.
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4◦C) and washed three times with 10ml PBS. Pellets were stored
at −80◦C. Cells were resuspended in 10ml PBS and autoclaved
(20min, 121◦C). For the growth curve analysis, cultures were
grown in 50ml TSB in 500ml flasks at 37◦C on a rotary shaker
at 160 rpm. The optical density was measured every hour at
578 nm using Ultraspec 1100 pro spectrophotometer (Amersham
Biosciences, Freiburg, Germany).
CONSTRUCTION OF AHemB-MUTANT IN S. AUREUS 8325-4
The hemB knockout mutant of S. aureus 8325-4 was constructed
by allelic replacement of the hemB gene with ermB cassette
(mediating erythromycin resistance) using the vector pCE8 as
described before (von Eiff et al., 1997). The mutant was verified
by restriction analysis and sequencing.
ISOTOPOLOGUE PROFILING
Bacterial cells (approximately 5mg) were suspended in 0.5ml
of 6M hydrochloric acid and incubated at 105◦C for 24 h.
The amino acids were purified on a Dowex 50W×8 col-
umn (washing 2 × 750 μl H20; developing 1ml 2M ammo-
nium hydroxide). The eluate was dried under a steam of
nitrogen and resuspended in 50μl dry acetonitrile. 50μl
of N-(tert-butyldimethylsilyl)-N-methyl-trifluoroacetamide con-
taining 1 % of tert-butyldimethylsilylchlorid were added
and the mixture was incubated at 70◦C for 30min. The
tert-butyl-dimethylsilyl derivatives of amino acids were then
used for gas chromatography–mass spectrometry (GC/MS)
and isotopolog analysis as described elsewhere (Eylert et al.,
2008).
FIGURE 3 | 13C-Excess in alanine, aspartate and glutamate from
S. aureus strains grown with [U-13C6]glucose. Columns represent
the mean values of three technical replicates; heme-auxotrophic (A),
thymidine-auxotrophic (B) and menadione-auxotrophic (C). Strain pairs
I, III, and V represent clinical isolates consisting of a normal
phenotype (WT) and a SCV phenotype (SCV). Strain pairs II, IV,
and VI consist of a normal phenotype and an in vitro generated
SCV phenotype.
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SEMI-QUANTITATIVE RT-PCR
Total RNA was extracted from bacteria grown in TSB medium to
late exponential growth phase using QuantiTect reverse transcrip-
tion kit (QIAGEN) according to the manufacturer’s recommen-
dations. PCR reaction were performed with the CFX96 system
(Bio-Rad Laboratories, München, Germany) under the following
conditions: 95◦C for 15min, 50 cycles (95◦C for 10 s, 10 s at 55◦C
for 10 s, 72◦C for 30 s) using the EvaGreen Kit (Segentic, Borken,
Germany). Three independent biological replicates were tested in
duplicate. N-fold expression values relative to the house-keeping
genes gyrB, gmk and aroE (normalized by the geometric mean of
the relative quantities of all three reference genes) and for each
strain set normalized to expression of the wild type isolate were
calculated using CFX Manager v3.1 (Bio-Rad).
RESULTS AND DISCUSSION
S. aureus SCVs show many common features, such as slow
growth, reduced pigmentation and changed expression of viru-
lence determinants, independent of their underlying auxotrophic
phenotype, molecular mechanism of SCV phenotype genera-
tion or genetic strain background. A similar phenotypic appear-
ance may reflect analogous metabolic properties or a similar
metabolic status. To investigate the metabolic differences (i)
between S. aureus normal and SCV phenotypes and (ii) between
different kinds of SCVs by isotopolog profiling, respective iso-
genic strains sets were analyzed (Table 1) and regulatory dif-
ferences in central metabolic and virulence related genes were
determined.
Using a S. aureus strain “sextet,” consisting of three wild type
isolates and three isolates displaying different SCV phenotypes
including a clinically derived SCV, a site-directed hemB mutant
and a gentamicin induced SCV, we identified significant pheno-
typic specific differences in the labeling patterns of amino acids
(Figures 1A–C) (Kriegeskorte et al., 2011). In experiments with
2.5 g/l [U-13C6]glucose as a supplement to the TSB medium, all
isolates, independent of their phenotype, showed high 13C incor-
poration of about 20–40% into alanin (Figures 1A, 7A), reflecting
a high glycolytic activity in both phenotypes. As expected, under
in vitro nutrient rich conditions, glucose served as the major
energy source for growth of S. aureus. Nevertheless, the fraction
of unlabeled amino acids in the experiment with [U-13C6]glucose
reflected the pronounced capacity of S. aureus to uptake and
to use external (unlabeled) amino acids or peptides from the
medium. In comparison to alanine, more pronounced differ-
ences were noticed in the labeling patterns of glutamate and
aspartate (Figures 1B,C). While all normal phenotypes showed
a 13C-excess between 11.8 and 16.0% in aspartate and gluta-
mate, all SCV phenotypes were characterized by a substantial
reduced 13C-excess between 0.7 and 4.4% (Figure 1A). As glu-
tamate and aspartate are directly linked to the citric acid cycle
intermediates α-ketoglutarate and oxalacetate, respectively, via
transamination, the reduced 13C-label of these amino acids could
indicate a reduced citric acid cycle activity in all SCV phenotypes
(Figure 5). The comparison of the averaged 13C-excess values
between the three normal and the three SCV phenotypes revealed
no significant differences in the 13C-excess of alanine, but a sig-
nificant reduction of the 13C-excess of aspartate and glutamate in
the SCV phenotypes (Figure 7A). Moreover, the isotopolog dis-
tributions in aspartate and glutamate from the SCVs were clearly
different from the corresponding patterns in aspartate and glu-
tamate from the wild-type phenotype and the revertant or com-
plemented strains (Figures 1B,C). Whereas the later group was
characterized by multiple 13C-isotopologs also comprising three
and more 13C-atoms, the amino acids from the SCVs displayed
higher fractions of 13C1-isotopologs. Again, this could reflect that
the carbon flux via the citrate cycle producing oxaloacetate/Asp
and α-ketoglutarate/Glu carrying multiple 13C-atoms in the
FIGURE 4 | Isotopologue composition of aspartate. Comparison between
normal and SCV phenotypes of S. aureus displaying different auxotrophisms.
Heme-auxotrophic (A), thymidine-auxotrophic (B) andmendione-auxotrophic
(C). Strain pairs I, III, and V represent clinical isolates. Strain pairs II, IV, and VI
consist of a normal phenotype and an in vitro generated SCV phenotype.
Patterned columns represent the mean values of three technical replicates.
The relative contributions of each 13C-isotopolog (M+1–M+4) with regard to
the overall enrichment were shown.
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experiments with [U-13C6]glucose is substantially reduced in the
hemBmutant and the gentamicin induced SCVs. This hypothesis
is in line with earlier conclusions made on the basis of proteome
and transcriptome studies (Kohler et al., 2003, 2008; Seggewiss
et al., 2006).
Interestingly, the clinical SCV showed similar patterns of the
13C-excess in aspartate and glutamate, in comparison to the
profiles from the site-directed hemB mutant and to the gentam-
icin induced SCV, respectively (Figure 1A). However, the relative
isotopolog distributions differed between the SCV phenotypes
(Figures 1B,C). While in the hemBmutant and in the gentamicin
induced SCV, the M+1 species were dominant, the 13C2-species
were more abundant indicating that single runs, but no multiple
runs, via the citric acid cycle were still operative in the clini-
cally derived SCV. To investigate whether reduced carbon flux
via the citrate cycle is a general feature of S. aureus SCVs that
also includes the major auxotrophic phenotypes (hemin, mena-
dione, and thymidine), we analyzed a comprehensive set of six
isogenic strain sets, each comprising the normal wild type and
different SCV phenotypes including clinical derived SCVs and
genetically defined mutants displaying the SCV phenotype. The
growth properties of the strain pairs are shown in Figures 2A–C,
7B. All SCVs showed a pronounced growth defect compared
to their normal phenotypes, irrespective of the underlying aux-
otrophism and reached considerably lower optical densities under
aerobic conditions. Again, 13C incorporation into alanine was
highly efficient in all phenotypes and strains and no signifi-
cant difference between the normal and the SCV phenotypes
could be observed (Figures 3A–C, 7B). However, irrespective of
the underlying auxotrophism, all SCV phenotypes again showed
reduced 13C-incorporation into aspartate and glutamate, reveal-
ing the assumed reduced activity of carbon flux via the citric acid
cycle (Figures 3A–C, 7B). This conclusion was verified by the
isotopolog distribution as shown in Figures 4A–C. While all of
the normal phenotypes showed in aspartate high fractions of the
M+2 species, all SCVs were devoid of this species. In contrast,
the SCV phenotypes showed increased relative fractions of M+1
and M+3 species indicating the reduced flux via the citric acid
cycle with 13C2-isotopologs, but higher contributions of oxaloac-
etate/Asp formation by anaplerotic reactions [i.e., giving rise to
the 13C3-isotopologs by carboxylation of [U-13C3]pyruvate or
PEP in the SCVs (Figure 5)].
Previously, we could show that the expression of acnA (aconi-
tase) which catalyzes the first step of the TCA cycle (Figure 5),
was reduced in a clinical SCV as well as in a site-directed hemB
mutant (Seggewiss et al., 2006; Al Laham et al., 2007; Kriegeskorte
et al., 2011). With the recent isotopolog data, down-regulation
of acnA resulting in reduced carbon flux via the citric acid cycle
seems to be a common feature of the SCV metabolism irre-
spective of the underlying molecular mechanism leading to this
phenotype. Not surprisingly, all of the investigated clinical SCVs
comprising heme, menadione and thymidine auxotrophic phe-
notypes, respectively, displayed a transcriptional down-regulation
of acnA compared to their corresponding normal phenotype
(Figures 6A–C, 7A,B). This is in line with previous studies on
transcriptomic or proteomic level (Kohler et al., 2003; Seggewiss
et al., 2006). Along with the decreased metabolic activity, all SCVs
showed markedly reduced expression of the major virulence reg-
ulators hld and sigB. Hld is the effector molecule (a regulatory
RNA) of the agr system which regulates virulence determinants in
FIGURE 5 | Schematic view of central carbon metabolism in
S. aureus. Green arrows marked SCV specific differences
irrespective of the underlying auxotrophism compared to their
corresponding normal phenotypes. TCA: tricarboxylic acid cycle;
Involved genes (marked in red) and corresponding KEGG gene
identifier were shown.
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FIGURE 6 | Semi-quantitative rt-PCR. Quantification of the expression of
acnA, hld and sigB of different S. aureus strains displaying the SCV
phenotype compared to its respective isogenic wild-type isolate.
Expression data is normalized using three internal control genes (gmk,
aroE, and gyrB) and displayed relative to the corresponding wild-type
isolates (IWT, IIIWT, and VWT were set as 1). Isogenic strain pair IWT and
ISCV [heme auxotrophic (A)], isogenic strain pair IIIWT and IIISCV [thymidine
auxotrophic (B)] and isogenic strain pair VWT and VSCV [menadione
auxotrophic (C)] were shown.
S. aureus such as the major toxins hla (α-hemolysin) and hlb (β-
hemolysin). Corresponding to the reduced expression of hld, the
investigated SCV phenotypes showed a clearly reduced hemolytic
activity on Columbia blood agar plates (data not shown).
In conclusion, all SCV phenotypes irrespective of their aux-
otrophism and genetic background revealed down-regulation of
citric cycle activity as shown by the reduced 13C-incorporation
FIGURE 7 | Averaged 13C-Excess in alanine, aspartate and glutamate
from S.aureus normal and SCV phenotypes. (A) Columns represent the
averaged values ± standard deviation (SD) of the normal phenotypes (WT)
including S. aureus 3878 WT, REV and KM and the SCV phenotypes (SCV)
including S. aureus cSCV, hemB and G. (B) Columns represent the
averaged values ± standard deviation (SD) of the normal phenotypes (WT)
including S. aureus I-VIWT and the SCV phenotypes (SCV) including
S. aureus I-VISCV. Statistical significance was assessed in pairwise
comparison between WT and SCV for each amino acid with the two-tailed
Student’s t-test. ∗∗P < 0.01, ∗∗∗P < 0.001.
into aspartate and glutamate with modified isotopolog profiles,
as well as by down-regulation of acnA on the transcriptional level.
A reduced metabolic status of all kinds of SCVs may explain the
concordant major characteristics of the S. aureus SCV phenotypes
regardless of the mechanism of their formation.
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